SUDARSHAN PHARMA INDUSTRIES Financial Statement Analysis
|
||
|
The Revenues of SUDARSHAN PHARMA INDUSTRIES have increased by 8.95% YoY .
The Earnings Per Share (EPS) of SUDARSHAN PHARMA INDUSTRIES has decreased by -86.13 % YoY. |
||
SUDARSHAN PHARMA INDUSTRIES Last 5 Annual Financial Results
[BOM: 543828]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹505 Cr | ₹464 Cr | ₹461 Cr | ₹357 Cr | ₹193 Cr |
| Expenses | ₹465 Cr | ₹441 Cr | ₹447 Cr | ₹346 Cr | ₹186 Cr |
| Operating Profit (Excl OI) | ₹40 Cr | ₹23 Cr | ₹15 Cr | ₹11 Cr | ₹7.16 Cr |
| Other Income | ₹2.52 Cr | ₹2.61 Cr | ₹1.12 Cr | ₹0.46 Cr | ₹0.38 Cr |
| Interest | ₹16 Cr | ₹8.95 Cr | ₹5.40 Cr | ₹3.38 Cr | ₹3.23 Cr |
| Depreciation | ₹2.22 Cr | ₹1.24 Cr | ₹0.91 Cr | ₹0.87 Cr | ₹0.74 Cr |
| Profit Before Tax | ₹22 Cr | ₹15 Cr | ₹9.50 Cr | ₹7.14 Cr | ₹3.58 Cr |
| Profit After Tax | ₹16 Cr | ₹11 Cr | ₹7.04 Cr | ₹5.25 Cr | ₹2.67 Cr |
| Consolidated Net Profit | ₹16 Cr | ₹11 Cr | ₹7.04 Cr | ₹5.25 Cr | ₹2.67 Cr |
| Earnings Per Share (Rs) | ₹0.66 | ₹4.76 | ₹2.92 | ₹5.38 | ₹2.80 |
| PAT Margin (%) | 3.16 | 2.47 | 1.53 | 1.47 | 1.38 |
| ROE(%) | 13.33 | 10.77 | 10.76 | 20.08 | 11.87 |
| ROCE(%) | 14.42 | 13.75 | 15.25 | 18.67 | 13.01 |
| Total Debt/Equity(x) | 1.34 | 0.94 | 0.34 | 1.03 | 1.32 |
Key Financials |
||
| Market Cap | : | ₹ 1,024.8 Cr |
| Revenue (TTM) | : | ₹ 703.1 Cr |
| Net Profit(TTM) | : | ₹ 23.4 Cr |
| EPS (TTM) | : | ₹ 0.9 |
| P/E (TTM) | : | 43.8 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SUDARSHAN PHARMA INDUSTRIES | -2.2% | 11% | 34.4% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.8% | 7.3% | 15.6% |
| DIVIS LABORATORIES | 1.9% | 8.2% | 6.2% |
| TORRENT PHARMACEUTICALS | 0.6% | 12.6% | 43.9% |
| CIPLA | 0.2% | 6.3% | -4.5% |
| DR REDDYS LABORATORIES | -1.8% | -3.5% | -3.4% |
| MANKIND PHARMA | 1.4% | 6.7% | -3.4% |
| LUPIN | 0.4% | 6.5% | 29% |
| ZYDUS LIFESCIENCES | 1.1% | 6.7% | 16.7% |
SUDARSHAN PHARMA INDUSTRIES Revenues
[BOM: 543828]
| Y-o-Y | 8.95 % |
| 5 Yr CAGR | 27.13 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹505 Cr | 8.95 | |
| Mar2024 | ₹464 Cr | 0.48 | |
| Mar2023 | ₹461 Cr | 29.19 | |
| Mar2022 | ₹357 Cr | 84.69 | |
| Mar2021 | ₹193 Cr | - | |
SUDARSHAN PHARMA INDUSTRIES Operating Profit
[BOM: 543828]
| Y-o-Y | 75.00 % |
| 5 Yr CAGR | 53.64 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹40 Cr | 75.00 | |
| Mar2024 | ₹23 Cr | 55.30 | |
| Mar2023 | ₹15 Cr | 34.56 | |
| Mar2022 | ₹11 Cr | 52.37 | |
| Mar2021 | ₹7.16 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 60.57 % |
| 5 Yr CAGR | 20.80 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 7.9% | 60.57 | |
| Mar2024 | 4.92% | 54.72 | |
| Mar2023 | 3.18% | 3.92 | |
| Mar2022 | 3.06% | -17.52 | |
| Mar2021 | 3.71% | - | |
SUDARSHAN PHARMA INDUSTRIES Profit After Tax
[BOM: 543828]
| Y-o-Y | 39.28 % |
| 5 Yr CAGR | 56.32 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹16 Cr | 39.28 | |
| Mar2024 | ₹11 Cr | 62.78 | |
| Mar2023 | ₹7.04 Cr | 34.09 | |
| Mar2022 | ₹5.25 Cr | 96.41 | |
| Mar2021 | ₹2.67 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 27.94 % |
| 5 Yr CAGR | 23.01 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 3.16 % | 27.94 | |
| Mar2024 | 2.47 % | 61.44 | |
| Mar2023 | 1.53 % | 4.08 | |
| Mar2022 | 1.47 % | 6.52 | |
| Mar2021 | 1.38 % | - | |
SUDARSHAN PHARMA INDUSTRIES Earnings Per Share (EPS)
[BOM: 543828]
| Y-o-Y | -86.13 % |
| 5 Yr CAGR | -30.32 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.66 | -86.13 | |
| Mar2024 | ₹4.76 | 63.01 | |
| Mar2023 | ₹2.92 | -45.72 | |
| Mar2022 | ₹5.38 | 92.14 | |
| Mar2021 | ₹2.80 | - | |
SUDARSHAN PHARMA INDUSTRIES Return on Capital Employed (ROCE)
[BOM: 543828]
| Y-o-Y | 4.87 % |
| 5 Yr CAGR | 2.61 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 14.42% | 4.87 | |
| Mar2024 | 13.75% | -9.84 | |
| Mar2023 | 15.25% | -18.32 | |
| Mar2022 | 18.67% | 43.50 | |
| Mar2021 | 13.01% | - | |
SUDARSHAN PHARMA INDUSTRIES Share Price vs Sensex
| Current Share Price | : | ₹41.0 |
| Current MarketCap | : | ₹ 1,024.8 Cr |
| Updated EOD on | : | Jul 20,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDARSHAN PHARMA INDUSTRIES | -2.2% |
11% |
34.4% |
| SENSEX | 0.1% |
0.7% |
-6.6% |
SUDARSHAN PHARMA INDUSTRIES related INDICES
You may also like the below Video Courses
FAQ about SUDARSHAN PHARMA INDUSTRIES Financials
How the annual revenues of SUDARSHAN PHARMA INDUSTRIES have changed ?
The Revenues of SUDARSHAN PHARMA INDUSTRIES have increased by 8.95% YoY .
How the Earnings per Share (EPS) of SUDARSHAN PHARMA INDUSTRIES have changed?
The Earnings Per Share (EPS) of SUDARSHAN PHARMA INDUSTRIES has decreased by -86.13 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs